423Indexed trials
Market Rank #4 · Evidence Tier A
China
Neuroscience Intelligence
China neuroscience intelligence: 423 indexed trials, 523 institutions, research score 52.08.
147Recruiting
523Research institutions
52.1Research score
Evidence profile
215Sponsors
29Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 52.1 · Data confidence 100.00 · Evidence 52.1
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
parkinsons66trials
stroke63trials
alzheimers44trials
epilepsy41trials
autism31trials
depression27trials
adhd24trials
other_neurology24trials
multiple_sclerosis13trials
schizophrenia12trials
Leading indexed sponsors
Merck Sharp & Dohme LLC15trials
Xuanwu Hospital, Beijing14trials
Beijing Tiantan Hospital13trials
Shanghai Mental Health Center13trials
Xijing Hospital13trials
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine11trials
Children's Hospital of Fudan University11trials
Ruijin Hospital10trials
Second Affiliated Hospital, Zhejiang University, School of Medicine9trials
Hoffmann-La Roche7trials